| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0123c1dfd65caa2cf0e4ad7ebf33491 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2014-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50f7d5785018dad07a3959f1b715895a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c21270864893de6863f4381b0d84ef6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea5e33d264305148d99586bf86b92fe4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4599466c4fa044e10d98caeb80657478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e12e149d8754b09c573732dcfde2e63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280623c33f00415a315b076e2aa95da6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_496073ef359dc95e715a77cfb8dd4154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e33cd97e96ed5450c61164f469208c39 |
| publicationDate |
2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2933755-A1 |
| titleOfInvention |
Pyrimidopyrimidinones useful as wee-1 kinase inhibitors |
| abstract |
The present invention relates to compounds that are useful as inhibitors of the activity of Wee-1 kinase. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in the treatment of cancer and methods of treating cancer. |
| priorityDate |
2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |